Novartis CAR-T Gets FDA Panel Nod But The Class Has More Hurdles

Jul 14, 2017, 14:03 PM by Michael Croft

Bloomberg.com | Novartis wins over an FDA panel, but the road to commercial viability is long.

July 14, 2017 | Novartis wins over an FDA panel, but the road to commercial viability is long. Bloomberg.com